evertex fabrinology limited

TWSE:1470 Rapport sur les actions

Capitalisation boursière : NT$1.7b

evertex fabrinology Résultats passés

Passé contrôle des critères 3/6

evertex fabrinology's earnings have been declining at an average annual rate of -6.2%, while the Luxury industry saw earnings growing at 8.2% annually. Revenues have been declining at an average rate of 1.8% per year. evertex fabrinology's return on equity is 6.1%, and it has net margins of 9.2%.

Informations clés

-6.2%

Taux de croissance des bénéfices

-6.2%

Taux de croissance du BPA

Luxury Croissance de l'industrie8.2%
Taux de croissance des recettes-1.8%
Rendement des fonds propres6.1%
Marge nette9.2%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Recent updates

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Ventilation des recettes et des dépenses

Comment evertex fabrinology gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

TWSE:1470 Recettes, dépenses et bénéfices (TWD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 24651601010
31 Mar 2461345940
31 Dec 2365549960
30 Sep 2363749920
30 Jun 2371756970
31 Mar 23777411000
31 Dec 22845331060
30 Sep 22951501080
30 Jun 22968501130
31 Mar 22993861200
31 Dec 21895651130
30 Sep 21858671150
30 Jun 21773631070
31 Mar 2162625920
31 Dec 2063135960
30 Sep 20647321050
30 Jun 20695401130
31 Mar 20815721260
31 Dec 19818761280
30 Sep 19814791240
30 Jun 19802771220
31 Mar 19792621210
31 Dec 18754491160
30 Sep 18735471140
30 Jun 18704361110
31 Mar 18693401110
31 Dec 17701421130
30 Sep 17711421150
30 Jun 17703391140
31 Mar 17682401100
31 Dec 16686471070
30 Sep 16687501030
30 Jun 16713641000
31 Mar 1674562980
31 Dec 1576261980
30 Sep 1577063990
30 Jun 1574754970
31 Mar 1574362950
31 Dec 1474466880
30 Sep 1473857830
30 Jun 1474858800
31 Mar 1470742750
31 Dec 1366929730

Des revenus de qualité: 1470 has high quality earnings.

Augmentation de la marge bénéficiaire: 1470's current net profit margins (9.2%) are higher than last year (7.8%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: 1470's earnings have declined by 6.2% per year over the past 5 years.

Accélération de la croissance: 1470's earnings growth over the past year (7.5%) exceeds its 5-year average (-6.2% per year).

Bénéfices par rapport au secteur d'activité: 1470 earnings growth over the past year (7.5%) did not outperform the Luxury industry 11.2%.

Rendement des fonds propres

ROE élevé: 1470's Return on Equity (6.1%) is considered low.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y